Respiratory Testing Enters a Period of Recalibration
As pandemic-era practices give way to more tailored strategies, laboratories are reconsidering how much respiratory testing is appropriate for different patients and clinical situations.
As pandemic-era practices give way to more tailored strategies, laboratories are reconsidering how much respiratory testing is appropriate for different patients and clinical situations.
From assay validation to staffing and supply chain planning, labs can take steps to manage testing surges during flu and RSV season.
Multiplex RT-PCR assay detects SARS-CoV-2, influenza A and B, and RSV from nasal swabs with breakaway format for flexible testing.
Researchers developed a smartphone-controlled centrifugal microfluidic device that rapidly detects different subtypes of the influenza virus.
Read MoreResearchers developed a paper strip test using CRISPR technology that can quickly and accurately diagnose various influenza strains.
Read MoreRoche’s cobas liat COVID, Influenza A/B & RSV test, is a rapid RT-PCR assay that detects multiple respiratory viruses from a single sample.
Read MoreResearchers have developed an advanced electrostatic air sampler that enhances rapid detection of airborne influenza and coronavirus.
Read MoreQIAGEN’s QIAstat-Dx Respiratory Panel Plus, a syndromic testing tool for diagnosing respiratory infections, received FDA clearance.
Read MoreADLM’s new guidance on clinical testing for respiratory viral infections emphasizes the use of advanced diagnostic methods and sample types.
Read MoreResearchers demonstrated that metal-enhanced fluorescence probes could rapidly detect influenza virus proteins without complex lab equipment.
Read MoreEvidation has been awarded a contract by BARDA to fund the 2023 Influenza-like Illness (ILI) Detect & Protect Studies.
Read MoreA parallel test developed by Karius aims to improve treatment for serious diseases by diagnosing infections more rapidly and effectively.
Read MoreThe new biochip offers the potential to test multiple pathogens responsible for respiratory infections, such as COVID, RSV, and influenza.
Read MoreNew data provides a unique snapshot of the interplay among SARS-CoV-2, influenza, and respiratory syncytial virus (RSV).
Read MoreSAS and the Texas DSHS are teaming up on new public health dashboards powered by SAS Viya for tracking influenza data across the state.
Read MoreSekisui Diagnostics’ OSOM Ultra Plus Flu A&B Test is a rapid antigen test that takes only 10 minutes at the point of care.
Read MoreHologic Inc. announced that the FDA has granted 510(k) clearance for the company’s Panther Fusion SARS-CoV-2/Flu A/B/RSV assay.
Read MoreCue Health announced that it has made a De Novo submission to the FDA for full clearance of the Cue RSV Molecular Test.
Read More